Back

Increased AGE-RAGE axis stress in methamphetamine (MA) abuse and MA-induced psychosis: associations with oxidative stress and increased atherogenicity

Al-Hakeim, H.; Altufaili, M.; Alhaideri, A.; Almulla, A. F.; Moustafa, S.; Maes, M.

2023-01-23 psychiatry and clinical psychology
10.1101/2023.01.21.23284873 medRxiv
Show abstract

Background and aimsMethamphetamine (MA)-induced psychosis (MIP) is associated with increased oxidative toxicity (especially lipid peroxidation) and lowered antioxidant defenses. Advanced glycation end products (AGEs) cause oxidative stress upon ligand binding to AGE receptors (RAGE). There are no data on whether MA use may cause AGE-RAGE stress, and whether the latter is associated with MIP. MethodsThis case-control study recruited 60 patients with MA use disorder and 30 normal controls and measured serum levels of oxidative stress toxicity (OSTOX, lipid peroxidation), antioxidant defenses (ANTIOX), magnesium, copper, atherogenicity, and AGE, soluble RAGE (sRAGE), and computed a composite reflecting AGE-RAGE axis activity. FindingsMA dependence and use were accompanied by increased AGE, sRAGE, AGE-RAGE, OSTOX/ANTIOX, Castelli risk index 1 and atherogenic index of plasma, indicating that MA causes AGE-RAGE axis stress, oxidative damage, and atherogenicity. The severity of dependence and MA dose were strongly correlated with increased sRAGE concentrations. Increased AGE-RAGE stress was strongly associated with OSTOX, OSTOX/ANTIOX, and MA-induced intoxication symptoms, psychosis, hostility, excitation, and formal thought disorders. We found that 54.8% of the variance in MIP symptoms was explained by the regression on AGE-RAGE, the OSTOX/ANTIOX ratio, lowered magnesium, and increased copper, and that these biomarkers mediated the effects of increasing MA doses on MIP symptoms. We found that 36.0% of the variance in the atherogenicity indices was explained by OSTOX/ANTIOX, AGE-RAGE, and lowered magnesium. ConclusionsMA use causes intertwined increases in AGE-RAGE axis stress and oxidative damage, which together predict the severity of MIP symptoms and increased atherogenicity.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
Neuropsychopharmacology
134 papers in training set
Top 0.3%
9.2%
2
Frontiers in Psychiatry
83 papers in training set
Top 0.4%
7.2%
3
Translational Psychiatry
219 papers in training set
Top 1%
4.9%
4
Journal of Psychopharmacology
14 papers in training set
Top 0.1%
4.9%
5
The British Journal of Psychiatry
21 papers in training set
Top 0.2%
4.3%
6
Schizophrenia Research
29 papers in training set
Top 0.2%
3.6%
7
PLOS ONE
4510 papers in training set
Top 43%
2.9%
8
Molecular Psychiatry
242 papers in training set
Top 1%
2.7%
9
Psychiatry Research
35 papers in training set
Top 0.6%
2.7%
10
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.6%
2.6%
11
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.1%
2.6%
12
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.1%
2.4%
13
Psychological Medicine
74 papers in training set
Top 0.7%
2.4%
50% of probability mass above
14
Schizophrenia Bulletin
29 papers in training set
Top 0.3%
2.4%
15
Journal of Psychiatric Research
28 papers in training set
Top 0.3%
2.1%
16
Addiction Biology
47 papers in training set
Top 0.5%
1.9%
17
Psychopharmacology
59 papers in training set
Top 0.3%
1.9%
18
Scientific Reports
3102 papers in training set
Top 53%
1.9%
19
Acta Neuropsychiatrica
12 papers in training set
Top 0.3%
1.9%
20
European Neuropsychopharmacology
15 papers in training set
Top 0.2%
1.9%
21
Drug and Alcohol Dependence
37 papers in training set
Top 0.4%
1.8%
22
Journal of Affective Disorders
81 papers in training set
Top 0.9%
1.8%
23
NeuroImage: Clinical
132 papers in training set
Top 2%
1.8%
24
BMC Psychiatry
22 papers in training set
Top 0.3%
1.7%
25
JAMA Psychiatry
13 papers in training set
Top 0.2%
1.7%
26
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.2%
1.7%
27
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.6%
1.7%
28
American Journal of Psychiatry
20 papers in training set
Top 0.2%
1.7%
29
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.2%
1.3%
30
Biological Psychiatry
119 papers in training set
Top 2%
1.2%